Clinical trial
Randomised, Investigator-blinded, Controlled, Multicentre Comparative Study on the Treatment of Head Lice Infestation With 2 Dimeticone Preparations With Different Application Times and Compositions: Dimet 5® (100% Dimeticon) Versus Hedrin® Once Liquid Gel (4% Dimeticon + Nerolidol)
NCT04878276 is registered in ClinicalTrials.gov with Infectopharm Arzneimittel GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Investigator-blinded, Controlled, Multicentre Comparative Study on the Treatment of Head Lice Infestation With 2 Dimeticone Preparations With Different Application Times and Compositions: Dimet 5® (100% Dimeticon) Versus Hedrin® Once Liquid Gel (4% Dimeticon + Nerolidol)
- Lead sponsor
- Infectopharm Arzneimittel GmbH
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 17, 2021
- Completion date
- March 31, 2026
- Enrollment
- 240 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
head lice infestation, lice, pediculosis capitis